Catawba Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | $2.03M | Sell |
30,056
-529
| -2% | -$35.8K | 0.48% | 66 |
|
|
2018
Q1 | $2.22M | Sell |
30,585
-2,123
| -6% | -$154K | 0.53% | 62 |
|
|
2017
Q4 | $2.46M | Sell |
32,708
-2,081
| -6% | -$157K | 0.56% | 60 |
|
|
2017
Q3 | $2.68M | Buy |
34,789
+843
| +2% | +$64.8K | 0.6% | 56 |
|
|
2017
Q2 | $2.54M | Buy |
33,946
+1,925
| +6% | +$144K | 0.58% | 62 |
|
|
2017
Q1 | $2.13M | Buy |
32,021
+603
| +2% | +$40.1K | 0.46% | 67 |
|
|
2016
Q4 | $2.05M | Sell |
31,418
-589
| -2% | -$38.5K | 0.48% | 65 |
|
|
2016
Q3 | $2.27M | Sell |
32,007
-1,630
| -5% | -$115K | 0.54% | 61 |
|
|
2016
Q2 | $2.49M | Buy |
33,637
+273
| +0.8% | +$20.2K | 0.6% | 56 |
|
|
2016
Q1 | $2.17M | Buy |
33,364
+78
| +0.2% | +$5.06K | 0.55% | 59 |
|
|
2015
Q4 | $2.57M | Buy |
33,286
+391
| +1% | +$30.1K | 0.7% | 49 |
|
|
2015
Q3 | $2.71M | Sell |
32,895
-486
| -1% | -$40K | 0.74% | 47 |
|
|
2015
Q2 | $2.94M | Sell |
33,381
-507
| -1% | -$44.7K | 0.7% | 49 |
|
|
2015
Q1 | $2.99M | Buy |
33,888
+1,082
| +3% | +$95.6K | 0.69% | 50 |
|
|
2014
Q4 | $2.72M | Hold |
32,806
| – | – | 0.63% | 53 |
|
|
2014
Q3 | $2.77M | Buy |
32,806
+140
| +0.4% | +$11.8K | 0.64% | 59 |
|
|
2014
Q2 | $2.65M | Buy |
32,666
+223
| +0.7% | +$18.1K | 0.6% | 62 |
|
|
2014
Q1 | $2.47M | Hold |
32,443
| – | – | 0.59% | 65 |
|
|
2013
Q4 | $2.34M | Buy |
32,443
+2,137
| +7% | +$154K | 0.56% | 65 |
|
|
2013
Q3 | $2.08M | Buy |
30,306
+210
| +0.7% | +$14.4K | 0.55% | 67 |
|
|
2013
Q2 | $1.91M | Buy |
+30,096
| New | +$1.91M | 0.53% | 68 |
|